Óscar Nantes

652 total citations
34 papers, 227 citations indexed

About

Óscar Nantes is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Óscar Nantes has authored 34 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 15 papers in Genetics and 9 papers in Epidemiology. Recurrent topics in Óscar Nantes's work include Inflammatory Bowel Disease (15 papers), Eosinophilic Esophagitis (10 papers) and Microscopic Colitis (8 papers). Óscar Nantes is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Eosinophilic Esophagitis (10 papers) and Microscopic Colitis (8 papers). Óscar Nantes collaborates with scholars based in Spain, United States and Switzerland. Óscar Nantes's co-authors include Javier Molina‐Infante, José Manuel Zozaya, Juan J. Vila, Saioa Rubio Iturria, Joaquín Rodríguez‐Sánchez, Isabel Pérez‐Martínez, Ángel Arias, Alfredo J. Lucendo, Jésus Barrio and Fernando Borda and has published in prestigious journals such as British Journal of Haematology, Alimentary Pharmacology & Therapeutics and Endoscopy.

In The Last Decade

Óscar Nantes

30 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Óscar Nantes Spain 9 139 102 52 37 23 34 227
Nadia Fathallah France 12 325 2.3× 133 1.3× 52 1.0× 58 1.6× 3 0.1× 58 399
Florian Poullenot France 9 84 0.6× 32 0.3× 130 2.5× 102 2.8× 38 1.7× 36 283
D Wilson-Storey United Kingdom 13 315 2.3× 56 0.5× 18 0.3× 27 0.7× 7 0.3× 28 376
Tao Yao China 9 87 0.6× 43 0.4× 67 1.3× 61 1.6× 12 0.5× 22 206
F Abbasakoor United Kingdom 8 175 1.3× 46 0.5× 12 0.2× 82 2.2× 37 1.6× 16 231
S. Pretlove United Kingdom 8 177 1.3× 166 1.6× 160 3.1× 24 0.6× 7 0.3× 15 434
Viktor Domislović Croatia 11 73 0.5× 19 0.2× 49 0.9× 178 4.8× 36 1.6× 45 308
M. Harrer Austria 6 148 1.1× 22 0.2× 166 3.2× 95 2.6× 10 0.4× 9 279
Berendt W. Aichbichler Austria 10 151 1.1× 34 0.3× 158 3.0× 93 2.5× 23 1.0× 15 330
Wolfgang Mohl Germany 9 134 1.0× 30 0.3× 79 1.5× 64 1.7× 18 0.8× 32 229

Countries citing papers authored by Óscar Nantes

Since Specialization
Citations

This map shows the geographic impact of Óscar Nantes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Óscar Nantes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Óscar Nantes more than expected).

Fields of papers citing papers by Óscar Nantes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Óscar Nantes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Óscar Nantes. The network helps show where Óscar Nantes may publish in the future.

Co-authorship network of co-authors of Óscar Nantes

This figure shows the co-authorship network connecting the top 25 collaborators of Óscar Nantes. A scholar is included among the top collaborators of Óscar Nantes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Óscar Nantes. Óscar Nantes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lucendo, Alfredo J., Óscar Nantes, Alex Straumann, et al.. (2024). Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis. Alimentary Pharmacology & Therapeutics. 61(3). 444–455. 3 indexed citations
2.
Elosua, Alfonso, María Rullán, Saioa Rubio Iturria, et al.. (2021). Does capsule endoscopy impact clinical management in established Crohn's disease?. Digestive and Liver Disease. 54(1). 118–124. 6 indexed citations
3.
Elosua, Alfonso, et al.. (2021). Use of capsule endoscopy in inflammatory bowel disease in clinical practice in Spain. Results from a national survey. Gastroenterología y Hepatología (English Edition). 44(10). 696–703. 2 indexed citations
4.
Rodríguez, Cristina, Alfonso Elosua, Carlos Prieto, et al.. (2021). Colectomy rate in ulcerative colitis 15 years after diagnosis: Results from the 2001-2003 Navarra cohort. Gastroenterología y Hepatología (English Edition). 45(1). 1–8. 1 indexed citations
5.
Iturria, Saioa Rubio, et al.. (2021). Tofacitinib, useful option for the treatment of pyoderma gangrenosum in an ulcerative colitis patient. Revista Española de Enfermedades Digestivas. 113(10). 733–734. 9 indexed citations
6.
Rodríguez, Cristina, Alfonso Elosua, Carlos Prieto, et al.. (2021). Tasas de colectomía en colitis ulcerosa 15 años después del diagnóstico. Datos de la cohorte Navarra 2001-2003. Gastroenterología y Hepatología. 45(1). 1–8. 1 indexed citations
7.
Rullán, María, et al.. (2020). Ustekinumab in Crohn's disease: Effectiveness and safety in clinical practice. Gastroenterología y Hepatología (English Edition). 43(9). 497–505. 4 indexed citations
8.
Rullán, María, et al.. (2020). Ustekinumab en enfermedad de Crohn: efectividad y seguridad en práctica clínica. Gastroenterología y Hepatología. 43(9). 497–505. 5 indexed citations
9.
Merino, Olga, Cristina Rodríguez, Óscar Nantes, et al.. (2018). Adalimumab treatment of anti-TNF-naïve patients with ulcerative colitis: Deep remission and response factors. Digestive and Liver Disease. 50(8). 812–819. 10 indexed citations
10.
11.
Rodríguez–Lago, Iago, et al.. (2016). Previous exposure to biologics and C-reactive protein are associated with the response to tacrolimus in inflammatory bowel disease. Revista Española de Enfermedades Digestivas. 108(9). 550–7. 2 indexed citations
12.
Nantes, Óscar, José Manuel Zozaya, Ramón Montes, & José Hermida. (2014). Lesiones gastrointestinales y características de las hemorragias digestivas agudas en los pacientes anticoagulados con acenocumarol. Gastroenterología y Hepatología. 37(6). 334–341. 3 indexed citations
13.
Lucendo, Alfredo J., Marta Sánchez-Cazalilla, Javier Molina‐Infante, et al.. (2014). Transcultural adaptation and validation of the "Adult Eosinophilic Esophagitis Quality of Life Questionnaire" into Spanish.. PubMed. 106(6). 386–94. 20 indexed citations
14.
15.
Nantes, Óscar, et al.. (2009). Incidencia y características de la Esofagitis Eosinofílica (EE) en adultos, en nuestro medio.. Anales del Sistema Sanitario de Navarra. 32(2). 227–234. 2 indexed citations
16.
Nantes, Óscar, et al.. (2009). Increased risk of esophageal perforation in eosinophilic esophagitis. Endoscopy. 41(S 02). E177–E178. 11 indexed citations
17.
Montes, Ramón, Óscar Nantes, Álvaro Alonso, José Manuel Zozaya, & José Hermida. (2008). The influence of polymorphisms of VKORC1 and CYP2C9 on major gastrointestinal bleeding risk in anticoagulated patients. British Journal of Haematology. 143(5). 727–733. 8 indexed citations
18.
Nantes, Óscar, et al.. (2008). Pustulosis exantemática aguda generalizada inducida por omeprazol. Gastroenterología y Hepatología. 31(5). 295–298. 9 indexed citations
19.
Vila, Juan J., F.J. Jiménez, Mercedes Iñarrairaegui, et al.. (2006). Informed consent document in gastrointestinal endoscopy: understanding and acceptance by patients. Revista Española de Enfermedades Digestivas. 98(2). 101–11. 18 indexed citations
20.
Nantes, Óscar, et al.. (2005). Síndrome general y diarrea como manifestación de infección por Giardia lamblia. Gastroenterología y Hepatología. 28(9). 558–560. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadia Fathallah Breakdown of academic impact, for papers by Florian Poullenot Breakdown of academic impact, for papers by D Wilson-Storey Breakdown of academic impact, for papers by Tao Yao Breakdown of academic impact, for papers by F Abbasakoor Breakdown of academic impact, for papers by S. Pretlove Breakdown of academic impact, for papers by Viktor Domislović Breakdown of academic impact, for papers by M. Harrer Breakdown of academic impact, for papers by Berendt W. Aichbichler Breakdown of academic impact, for papers by Wolfgang Mohl
Rankless by CCL
2026